Latest Breaking News On - Research development at ipsen - Page 1 : comparemela.com

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume responsibility.

France generalUnited statesJess smithSergey paushkinMaura mcmarthySteve glymanAmy wolfIpsen euronextResearch development at ipsenSkyhawk therapeuticsChief scientific officerRare diseaseSponsored leveli american depositary receiptFrench autoritDes marchUniversal registration document

Newswire & Press Release / Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases - Pharma / BioTech / Nutrition - IPSEN Group

Newswire & Press Release / Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases - Pharma / BioTech / Nutrition - IPSEN Group
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.

France generalMaura mcmarthyJess smithSteve glymanSergey paushkinResearch development at ipsenResearch collaboration in rare neurological diseasesAgency sourceSkyhawk therapeuticsBanner ad hereNutrition announcementsAffiliate programsChief scientific officerRare diseaseFrench autoritDes march

Newswire & Press Release / Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases - Pharma / BioTech / Nutrition - IPSEN Group

France generalSergey paushkinSteve glymanJess smithMaura mcmarthyAgency sourceResearch collaboration in rare neurological diseasesResearch development at ipsenSkyhawk therapeuticsBanner ad hereNutrition announcementsAffiliate programsChief scientific officerRare diseaseFrench autoritDes march